US SB5029 | 2023-2024 | 118th Congress
Status
Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on September 12 2024 - 25% progression
Action: 2024-09-12 - Read twice and referred to the Committee on Finance.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on September 12 2024 - 25% progression
Action: 2024-09-12 - Read twice and referred to the Committee on Finance.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]
Summary
A bill to amend title XI of the Social Security Act to establish a research and development-intensive small biotech manufacturer exception from the Medicare drug price negotiation program.
Title
Small Biotech Innovation Act
Sponsors
| Sen. Bill Cassidy [R-LA] |
History
| Date | Chamber | Action |
|---|---|---|
| 2024-09-12 | Senate | Read twice and referred to the Committee on Finance. |
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/118th-congress/senate-bill/5029/all-info |
| Text | https://www.congress.gov/118/bills/s5029/BILLS-118s5029is.pdf |
